Top Qs
Timeline
Chat
Perspective
Schaaf–Yang syndrome
Human genetic disorder From Wikipedia, the free encyclopedia
Remove ads
Schaaf–Yang syndrome (SYS) is a rare genetic disorder that is caused by a heterozygous mutation in a paternal-expressed gene MAGEL2.[2] Main signs of this disorder are: intellectual disability/developmental delay, autism spectrum disorder, hypogonadism, hypotonia in infancy with feeding problems, and distal arthrogryposis.[3] Facial features are: short noses, dense eyebrows, and protruding jaw.[4]
Remove ads
Signs and symptoms
Symptoms of this disease are:[5]
Very frequent
- Facial shape abnormality
- Undescended testis
- Feeding problems
- Hypotonia
- Flexion contracture
- Delay of Neurodevelopment
Frequent
- Visceral obesity
- Temper tantrums
- Eye problems
- Lack of pubertal development
- Unusual behaviour
- Autistic behaviour
- Chronic constipation
- External genital hypoplasia
- Borderline/Mild Intellectual disability
- Kyphosis
- Scoliosis
- Sleep apnea
- Squint eye
- Temperature regulation problems
- Failure to thrive
- Gastroesophageal reflux disease
- Hypogonadism
- Enlargment of сerebral ventricles
Occasional
- Almond-shaped eyes
- Atrial septal defect
- Hypothyroidism
- Central sleep apnea
- Downturned corners of mouth
- Thin nasal bridge
- Thin upper lip
- Seizure
- Abnormal dryness of the mouth
- Type II diabetes
Remove ads
Cause
The cause of this disease are mutation in a gene MAGEL2 which is located on chromosome 15 (15q11.2) and that gene is expressed from paternal chromosome 15 and methylated on maternal chromosome 15.[6][7] The MAGEL2 is a part of regulatory complex MUST, which consist of MAGEL2-USP7-TRIM27.[8][9] This complex regulates WASH complex which function is to promotes endosomal actin polymerization.[10] 50% of people with SYS inherited mutation from their father and remainder are de novo mutation (which means that mutation is new and none of the parents have it).[7][11]
MAGEL2-regulated WASH complex is important for the regulated secretion in the hypothalamus.[12] MAGEL2 mutation causes decreased secretion of hormones, such as: oxytocin, AVP, somatostatin, thyrotropin-releasing hormone, growth hormone, and luteinizing hormone.[13][14] Loss of that protein also showed neuronal activity loss in the hypothalamus and hippocampus of mice by disruptions of neuronal activity and changes in the synaptic excitation/inhibition balance through AMPA receptor trafficking defects.[15][16]
Remove ads
Diagnosis
SYS can be suspected by symptoms and subsequently can be diagnosed by genetic testing.[17]
Treatment
SYS doesn't have a cure.[7] Although symptomatic management is available, It might be effective but it still doesn't alleviate overall impact of SYS, which leaves caregivers unsatisfied.[18]
Prognosis
Life expectancy of person with SYS can be reduced due to fatal complication.[7] Survival into adulthood is possible and oldest patient with SYS is 36 years olds (at the time of article's publication).[19]
History
The first mention of SYS-like symptoms was described by Chitayat et al. (1990).[20] Although the name was coined by Christian P Schaaf and Yaping Yang, who described SYS in details in 2013.[21]
Prevalence
The prevalence of SYS is < 1/1,000,000.[22][19] Currently, it is estimated that about 250 people are diagnosed with SYS.[23]
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads